|
Código del ensayo TESARO 3000-04-001 |
|
Ensayo Post-authorization safety study to evaluate the risks of myelodysplastic syndrome/acute myeloid leukemia and second primary malignancies in adult patients with platinum-sensitive, relapsed, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer receiving maintenance treatment with ZEJULA® (niraparib) |
|
Estado En proceso de aprobación |
|
Tipo de ensayo Observacional prospectivo |
|
Tipo de terapia No intervención |
|
Situación clínica |
|
Tipo de patología Genitourinario |
|
Centro Hospital Universitario de Guadalajara |
